Added to YB: 2026-04-22
Pitch date: 2026-04-20
SEER [neutral]
Seer, Inc.
Author Info
Stock Pursuit researches domestic deep value equities below net cash, net current asset value or net tangible assets. Sign up for the newsletter.
Company Info
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa.
Market Cap
$112.8M
Pitch Price
$2.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.68
P/E
-1.56
EV/Sales
-2.98
Sector
Life Sciences Tools and Services
Category
special_situation
Deep Value Roundup Part II - Seer, Inc.
SEER (holding update): Proteomics platform co trading below net cash (~$3.00/share). Received $2.25/share buyout offer from Radoff-JEC Group (+12% vs $2.00 close), but author hopes board rejects as price below net cash. Previously covered as AI-driven thesis; comp Somalogic acquired by LAB at premium. Similar to earlier net cash biotech plays.
Read full article (1 min)